How the TP53 Family Proteins TP63 and TP73 contribute to tumorigenesis: Regulators and effectors

Eleonora Candi, Massimiliano Agostini, Gerry Melino, Francesca Bernassola

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

In mammals, the p53 family comprises two additional members, p63 and p73 (hereafter referred to as TP53, TP63, and TP73, respectively). The usage of two alternative promoters produces protein variants either with (transactivating [TA] isoforms) or without (ΔN isoforms) the N-terminal transactivation domain (TAD). In general, the TA proteins exert TP53-like tumor-suppressive activities through their ability to activate a common set of target genes. The ΔN proteins can act as dominant-negative inhibitors of the transcriptionally active family members. Additionally, they possess intrinsic-specific biological activities due to the presence of alternative TADs, and as a result of engaging a different set of regulators. This review summarizes the current understanding of upstream regulators and downstream effectors of the TP53 family proteins, with particular emphasis on those that are relevant for their role in tumorigenesis. Furthermore, we highlight the existence of networks and cross-talks among the TP53 family members, their modulators, as well as the transcriptional targets.

Original languageEnglish
Pages (from-to)702-714
Number of pages13
JournalHuman Mutation
Volume35
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Tumor Suppressor Protein p53
Carcinogenesis
Protein Isoforms
Aptitude
Transcriptional Activation
Mammals
Proteins
Genes
Neoplasms

Keywords

  • Cellular metabolism
  • MicroRNA
  • P53
  • P63
  • P73
  • TP53
  • TP63
  • TP73
  • Ubiquitylation

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

How the TP53 Family Proteins TP63 and TP73 contribute to tumorigenesis : Regulators and effectors. / Candi, Eleonora; Agostini, Massimiliano; Melino, Gerry; Bernassola, Francesca.

In: Human Mutation, Vol. 35, No. 6, 2014, p. 702-714.

Research output: Contribution to journalArticle

Candi, Eleonora ; Agostini, Massimiliano ; Melino, Gerry ; Bernassola, Francesca. / How the TP53 Family Proteins TP63 and TP73 contribute to tumorigenesis : Regulators and effectors. In: Human Mutation. 2014 ; Vol. 35, No. 6. pp. 702-714.
@article{0cb2d31f0fa94f52abc18766f633bc8a,
title = "How the TP53 Family Proteins TP63 and TP73 contribute to tumorigenesis: Regulators and effectors",
abstract = "In mammals, the p53 family comprises two additional members, p63 and p73 (hereafter referred to as TP53, TP63, and TP73, respectively). The usage of two alternative promoters produces protein variants either with (transactivating [TA] isoforms) or without (ΔN isoforms) the N-terminal transactivation domain (TAD). In general, the TA proteins exert TP53-like tumor-suppressive activities through their ability to activate a common set of target genes. The ΔN proteins can act as dominant-negative inhibitors of the transcriptionally active family members. Additionally, they possess intrinsic-specific biological activities due to the presence of alternative TADs, and as a result of engaging a different set of regulators. This review summarizes the current understanding of upstream regulators and downstream effectors of the TP53 family proteins, with particular emphasis on those that are relevant for their role in tumorigenesis. Furthermore, we highlight the existence of networks and cross-talks among the TP53 family members, their modulators, as well as the transcriptional targets.",
keywords = "Cellular metabolism, MicroRNA, P53, P63, P73, TP53, TP63, TP73, Ubiquitylation",
author = "Eleonora Candi and Massimiliano Agostini and Gerry Melino and Francesca Bernassola",
year = "2014",
doi = "10.1002/humu.22523",
language = "English",
volume = "35",
pages = "702--714",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - How the TP53 Family Proteins TP63 and TP73 contribute to tumorigenesis

T2 - Regulators and effectors

AU - Candi, Eleonora

AU - Agostini, Massimiliano

AU - Melino, Gerry

AU - Bernassola, Francesca

PY - 2014

Y1 - 2014

N2 - In mammals, the p53 family comprises two additional members, p63 and p73 (hereafter referred to as TP53, TP63, and TP73, respectively). The usage of two alternative promoters produces protein variants either with (transactivating [TA] isoforms) or without (ΔN isoforms) the N-terminal transactivation domain (TAD). In general, the TA proteins exert TP53-like tumor-suppressive activities through their ability to activate a common set of target genes. The ΔN proteins can act as dominant-negative inhibitors of the transcriptionally active family members. Additionally, they possess intrinsic-specific biological activities due to the presence of alternative TADs, and as a result of engaging a different set of regulators. This review summarizes the current understanding of upstream regulators and downstream effectors of the TP53 family proteins, with particular emphasis on those that are relevant for their role in tumorigenesis. Furthermore, we highlight the existence of networks and cross-talks among the TP53 family members, their modulators, as well as the transcriptional targets.

AB - In mammals, the p53 family comprises two additional members, p63 and p73 (hereafter referred to as TP53, TP63, and TP73, respectively). The usage of two alternative promoters produces protein variants either with (transactivating [TA] isoforms) or without (ΔN isoforms) the N-terminal transactivation domain (TAD). In general, the TA proteins exert TP53-like tumor-suppressive activities through their ability to activate a common set of target genes. The ΔN proteins can act as dominant-negative inhibitors of the transcriptionally active family members. Additionally, they possess intrinsic-specific biological activities due to the presence of alternative TADs, and as a result of engaging a different set of regulators. This review summarizes the current understanding of upstream regulators and downstream effectors of the TP53 family proteins, with particular emphasis on those that are relevant for their role in tumorigenesis. Furthermore, we highlight the existence of networks and cross-talks among the TP53 family members, their modulators, as well as the transcriptional targets.

KW - Cellular metabolism

KW - MicroRNA

KW - P53

KW - P63

KW - P73

KW - TP53

KW - TP63

KW - TP73

KW - Ubiquitylation

UR - http://www.scopus.com/inward/record.url?scp=84901244771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901244771&partnerID=8YFLogxK

U2 - 10.1002/humu.22523

DO - 10.1002/humu.22523

M3 - Article

C2 - 24488880

AN - SCOPUS:84901244771

VL - 35

SP - 702

EP - 714

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 6

ER -